General

DDSD Numbered Memo 2023-08 Developmental Disabilities - General September 19, 2023

Mandatory Use of Therap for Behavior Support Documentation

CDC and FDA Recommend Updated (2023-2024) COVID19 Vaccines Health Emergency Management - General September 15, 2023

On September 11, 2023, the FDA approved the 2023-2024 formulation of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 vaccines for everyone 6 months of age and older. The Advisory Committee on Immunization Practices (ACIP) voted on September 12, 2023, to recommend the updated vaccines and the CDC endorsed the ACIP recommendations the same day.

Response to PCG Rate Study Public Comments - 09/07/2023 Developmental Disabilities - General September 13, 2023

Response to PCG Rate Study Public Comments - 09/07/2023

Letter from Governor Michelle Lujan Grisham to U.S. Attorney General Merrick Garland Injury Prevention - General September 11, 2023

Letter from Governor Michelle Lujan Grisham to U.S. Attorney General Merrick Garland

DD Waiver Service Standards Draft-Snapshot of Edits Developmental Disabilities - General September 5, 2023

DD Waiver Service Standards Draft-Snapshot of Edits

DD Waiver Service Standards-Draft Developmental Disabilities - General September 5, 2023

DD Waiver Service Standards-Draft

DDSD Numbered Memo 2023-06 Developmental Disabilities - General September 5, 2023

Preview of DD Waiver Service Standards Edits and Opportunity for Feedback

Governors Proclamation Falls Prevention Awareness Week, Sept 18-22, 2023 Injury Prevention - General September 1, 2023

Governors Proclamation Falls Prevention Awareness Week, Sept 18-22, 2023

Governors Proclamation Suicide Prevention Month 2023 Injury Prevention - General August 31, 2023

Governors Proclamation Suicide Prevention Month 2023

CD Manual – Pneumococcal Disease Infectious Disease Surveillance - General August 30, 2023

CD Manual – Pneumococcal Disease

Pneumococcal Disease Factsheet (English) Infectious Disease Surveillance - General August 30, 2023

Pneumococcal Disease Factsheet (English)

Pneumococcal Disease Factsheet (Spanish) Infectious Disease Surveillance - General August 30, 2023

Pneumococcal Disease Factsheet (Spanish)

Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections Health Emergency Management - General August 28, 2023

Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections

Health Promotion Team – SE Region Information Sheet Health Promotion - General August 28, 2023

This document explains the mission statement, core values, and health promotion team vision of the Southeast Region Health Promotion Team. Staff and contact information listing.

Health Promotion Team – SE Region Legislative Fact Sheet Health Promotion - General August 28, 2023

This document explains the mission statement, core values, and health promotion team vision of the Southeast Region Health Promotion Team. Staff and contact information listing.

Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023 Health Emergency Management - General August 28, 2023

Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023

COVID-19 Update - Paxlovid Prescribing - August 24, 2023 Health Emergency Management - General August 28, 2023

As the number of COVID-19 cases rises across the US, the New Mexico Department of Health recommends that providers prescribe Paxlovid (nirmatrelvir/ritonavir) to all appropriate patients diagnosed with COVID-19. Paxlovid, an oral antiviral, is a highly effective treatment for COVID-19 but continues to be under prescribed by providers1. Support for the use of Paxlovid comes from several randomized trials and observational studies of symptomatic outpatients with COVID-19, which demonstrated a reduction in hospitalization and death.